Crop Life Science Limited (NSE:CLSL)

Crop Life Science Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	12.48	7.49	23.92	3.79	20.68
Short-Term Investments	22.34	1.99	2.7	-	-
Cash & Short-Term Investments	34.82	9.48	26.62	3.79	20.68
Cash Growth	267.35%	-64.39%	602.51%	-81.68%	-33.05%
Accounts Receivable	741.45	692.92	772.62	325.56	368.63
Other Receivables	0.26	0.06	-	0.06	-
Receivables	741.85	695.85	772.62	326.2	368.89
Inventory	705.56	488.94	398.18	261.88	222.61
Prepaid Expenses	3.72	6.43	-	70.85	21.25
Other Current Assets	280.64	221.1	202.43	192.81	180.89
Total Current Assets	1,767	1,422	1,400	855.52	814.32
Property, Plant & Equipment	275.68	354.48	363.03	152.43	123.07
Long-Term Investments	6.39	6.01	-	-	-
Goodwill	19.61	19.61	19.61	-	-
Other Intangible Assets	4.56	6.11	8.29	3.41	3.73
Long-Term Deferred Tax Assets	-	-	-	-	0.23
Other Long-Term Assets	6.7	9.05	7.9	4.5	4.42
Total Assets	2,080	1,817	1,799	1,016	945.78

Liabilities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	521.26	440.96	527.44	199.89	222.29
Accrued Expenses	18.01	18.64	37.76	48.76	41.66
Short-Term Debt	503.76	350.18	242.55	167.16	174.82
Current Portion of Long-Term Debt	8.24	28	13.42	37.73	17.72
Current Portion of Leases	9.03	9.89	7.81	7.57	2.18
Current Income Taxes Payable	5.16	0.84	2.73	-	1.5
Other Current Liabilities	72.77	79.4	97.23	86.26	92.83
Total Current Liabilities	1,138	927.92	928.94	547.37	553.01
Long-Term Debt	24.07	27.75	56.79	2.23	16.76
Long-Term Leases	20.58	27.33	33.45	0.62	3.79
Pension & Post-Retirement Benefits	8.45	8.22	5.3	4.84	12.04
Long-Term Deferred Tax Liabilities	5.69	9.08	12.83	-	-
Other Long-Term Liabilities	2.52	3.26	2.23	55.26	-
Total Liabilities	1,200	1,004	1,040	610.32	585.59

Shareholders' Equity

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	171.4	171.4	171.4	120	120
Additional Paid-In Capital	199.66	199.66	199.66	-	-
Retained Earnings	468.54	402.18	343.27	283.04	242.32
Comprehensive Income & Other	2.86	1.3	2.93	2.51	-2.14
Total Common Equity	842.46	774.54	717.26	405.54	360.19
Minority Interest	37.55	38.96	41.86	-	-
Shareholders' Equity	880.01	813.5	759.12	405.54	360.19
Total Liabilities & Equity	2,080	1,817	1,799	1,016	945.78

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	565.67	443.15	354.03	215.31	215.27
Net Cash (Debt)	-530.84	-433.67	-327.41	-211.52	-194.59
Net Cash Growth	-	-	-	-	-
Net Cash Per Share	-30.97	-25.30	-19.10	-17.63	-16.22
Filing Date Shares Outstanding	17.14	17.14	17.14	12.06	12
Total Common Shares Outstanding	17.14	17.14	17.14	12.06	12
Working Capital	628.37	493.88	470.9	308.15	261.32
Book Value Per Share	49.15	45.19	41.85	33.61	30.02
Tangible Book Value	818.29	748.82	689.36	402.13	356.46
Tangible Book Value Per Share	47.74	43.69	40.22	33.33	29.70
Land	33.5	86.71	85.73	-	5.6
Buildings	173.13	169.15	162.73	-	56.94
Machinery	220.22	204.53	179.71	-	76.22
Construction In Progress	-	-	-	-	14.48

Data Source: S&P Global Market Intelligence Last updated: Sep 24, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 21, 2026

Data Sources Report a data error